Discovery bioanalysis

In the dynamic landscape of drug discovery, identifying candidates with promising ADME (Absorption, Distribution, Metabolism, and Excretion) and pharmacokinetics properties is pivotal. These early-stage assessments lay the groundwork for future clinical trials and regulatory approvals.

However, the journey from discovery to successful outcomes demands more than just scientific insights. It requires reliable, qualified measurements at a clinical scale. That’s where IQVIA Laboratories global bioanalytical services network excels.

Our expertise spans a wide range of areas, including:

Bioanalysis for all non-regulated studies
Biological fluids, tissue homogenates, dried blood spot (DBS) and other micro-sampling techniques
Tiered offerings with varying level of rigor based on the program stage and needs
Tecan liquid handlers for sample processing and Watson LIMS for data efficiency
High throughput capacity and quick turnaround time
Flexible offerings from fit for purpose to method qualification
Plasma, serum, whole blood, urine, CSF and various tissue sample analysis for PK/PD, pharmacology, and non-regulated toxicology studies
Analysis for drug and metabolite(s) as needed and cassette study sample analysis
Flexible standard curve ranges with appropriate LLOQ as needed
Non-compartmental PK analysis and SEND data files
Non-regulated preclinical and clinical (exploratory purposes) sample analysis
Method development and transfer for regulated bioanalysis